Ibl Healthcare Stock Current Valuation

IBLHL Stock   47.09  3.67  8.45%   
Valuation analysis of IBL HealthCare helps investors to measure IBL HealthCare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
47.09
Please note that IBL HealthCare's price fluctuation is not too volatile at this time. Calculation of the real value of IBL HealthCare is based on 3 months time horizon. Increasing IBL HealthCare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
IBL HealthCare's intrinsic value may or may not be the same as its current market price of 47.09, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  47.09 Real  35.16 Hype  47.09 Naive  47.25
The intrinsic value of IBL HealthCare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence IBL HealthCare's stock price.
35.16
Real Value
51.80
Upside
Estimating the potential upside or downside of IBL HealthCare helps investors to forecast how IBL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IBL HealthCare more accurately as focusing exclusively on IBL HealthCare's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
36.9342.1247.32
Details
Hype
Prediction
LowEstimatedHigh
43.3147.0950.87
Details
Naive
Forecast
LowNext ValueHigh
43.4747.2551.04
Details

IBL HealthCare Company Current Valuation Analysis

IBL HealthCare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, IBL HealthCare has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Health Care Providers & Services (which currently averages 0.0) industry. The current valuation for all Pakistan stocks is 100.0% higher than that of the company.
IBL HealthCare is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care Providers & Services industry is currently estimated at about 0.0. IBL HealthCare adds roughly 0.0 in current valuation claiming only tiny portion of equities under Health Care Providers & Services industry.

About IBL HealthCare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IBL HealthCare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IBL HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IBL HealthCare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with IBL HealthCare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IBL HealthCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IBL HealthCare will appreciate offsetting losses from the drop in the long position's value.

Moving together with IBL Stock

  0.88FFL Fauji FoodsPairCorr
  0.8KSBP KSB PumpsPairCorr
  0.62MARI Mari Petroleum SplitPairCorr
  0.95LOADS LoadsPairCorr
The ability to find closely correlated positions to IBL HealthCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IBL HealthCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IBL HealthCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IBL HealthCare to buy it.
The correlation of IBL HealthCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IBL HealthCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IBL HealthCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IBL HealthCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in IBL Stock

IBL HealthCare financial ratios help investors to determine whether IBL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IBL with respect to the benefits of owning IBL HealthCare security.